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Abstract Multi-morbidity, dependency, and frailty
were studied simultaneously in a community-living co-
hort of 4,000 men and women aged 65 years and over to
examine the independent and combined effects on four
health outcomes (mortality, decline in physical function,
depression, and polypharmacy). The influence of socio-
economic status on these relationships is also examined.
Mortality data was documented after a mean follow-up
period of 9 years, while other health outcomes were
documented after 4 years of follow-up. Fifteen percent
of the cohort did not have any of these syndromes. Of
the remaining participants, nearly one third had multi-
morbidity and frailty (pre-frail and frail), while all three
syndromes were present in 11 %. All syndromes as well
as socioeconomic status were significantly associated
with all health outcomes. Mortality was only increased
for age, being male, frailty status, and combinations of
syndromes that included frailty. Both multi-morbidity
and frailtymale was protective. Only a combination of
all three syndromes, and age per se, increased the risk of
depressive symptoms at 4 years while being male con-
ferred reduced risk. Multi-morbidity, but not frailty sta-
tus or dependency, and all syndrome combinations that
included multi-morbidity were associated with use
of≥four medications. Decline in homeostatic function
with age may thus be quantified and taken into account
in prediction of various health outcomes, with a view to
prevention, management, formulation of guidelines, ser-
vice planning, and the conduct of randomized controlled
trials of interventions or treatment.
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Introduction
In the past decade, there is an increasing volume of
literature on the impact of multi-morbidity, dependency,
and frailty on health outcomes (Jarrett et al. 1995;
Cigolle et al. 2007; Carriere et al. 2005; Theou et al.
2012; Stineman et al. 2012;Ma et al. 2011; Rozzini et al.
2005; Koroukian 2009; Koroukian et al. 2010; Kadam
and Croft 2007; Fortin et al. 2006). Health outcomes
commonly include mortality, increasing functional lim-
itation, polypharmacy, psychological well-being, and
service utilization. Dependency is frequently represent-
ed by limitations in physical activity and/or measures of
self-care such as basic and instrumental activities of
daily living. Multi-morbidity is defined as coexistence
of more than one chronic medical condition, whether it
be physical or mental. Frailty represents a state of mul-
tisystem impairments resulting from age-related physi-
ological changes consequent to impaired homeostasis
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final state of disability and death. Definitions range from
the multi-deficits frailty index (Rockwood andMitnitski
2007) to the phenotypic definition proposed by Fried
(Fried et al. 2001) to practical bedside measures such as
the FRAIL score (Abellan van Kan et al. 2008) and the
Canadian Study of Health and Ageing clinical frailty
scale (Rockwood et al. 2005). Although the definitions of
dependency, multi-morbidity, and frailty are distinct, they
are overlapping syndromes (Fried et al. 2004), and com-
monly coexist among older populations. Better under-
standing of the interactive nature of these syndromes and
how they affect health outcomeswould guidemanagement
strategies in terms of prevention and intervention.
Different syndromes may have variable contribution
to different outcomes (Byles et al. 2005; Perruccio et al.
2007; Valderas et al. 2009; Huntley et al. 2012). Fur-
thermore, socioeconomic factors may modulate this re-
lationship (Lucchetti et al. 2009; Gobbens et al. 2010).
Few studies examined these syndromes simultaneously
in the same population to determine the extent of over-
lap, their variable independent and/or cumulative impact
on health outcomes, and how this relationship may be
affected by socioeconomic status (SES). These ques-
tions are addressed by a study of a community-living
cohort of 4,000 men and women aged 65 years and over
to examine the independent and combined effects of
multi-morbidity, dependency, and frailty on four health
outcomes (mortality, decline in physical function, de-
pression, and polypharmacy). The influence of socio-
economic status on these relationships is also examined.
Subjects and methods
Between 2001 and 2003, 4,000 men and women aged
65 years and over living in the community responded to
recruitment notices in community centers for the elderly
and housing estates for a health check carried out in the
School of Public Health of the Chinese University of
Hong Kong. The target was a stratified sample so that
approximately 33 % would be in each of these age
groups: 65–69, 70–74, and 75+. Exclusion criteria in-
cluded inability to walk independently, a history of
bilateral hip replacements, mental incapacity in giving
informed consent, and presence of medical conditions
that in the judgment of study doctors would reduce the
chance of survival during the next 4 years such as
cancer, end stage renal, heart, or chronic lung diseases
were excluded. The study was approved by the Clinical
Research Ethics Committee of the Chinese University
of Hong Kong, which requires informed consent to be
obtained.
A team administered a questionnaire and measure-
ments containing the following items: the number of
prescriptionmedications; any difficulties with performing
three items of instrumental activities of daily living
(IADL) (preparing own meals, doing housework such
as cleaning floors or windows, and doing own shopping
for groceries or clothes); any difficulties with exertional
physical activities such as climbing up ten steps without
resting or moving furniture; the presence or absence of
disease was based on subjects' report of diagnosis by their
doctors; depressive symptoms assessed using the Geriat-
ric Depression Scale (Yesavage et al. 1983) with a score
≥8 representing depressive symptoms, validated in elder-
ly Chinese subjects (Lee et al. 1993); and equivalent
items used for classification of frailty status using the
Cardiovascular Health Study score (Fried et al. 2001):
having no energy, grip strength measurement falling into
the first quartile, walking speed measurement in the
fourth quartile (i.e., slowest), Physical Activity Scale for
the Elderly (PASE) score (Washburn et al. 1993) in the
lowest quartile, and body mass index <18.5 kg/m2. The
maximum score of 5 represents the greatest degree of
frailty. A score of 1–2 represents a pre-frail state, while a
score of ≥3 represents frailty.
Walking speed was recorded by measuring the time
taken to walk 6 m. Body weight was measured with
subjects wearing a light gown, by the Physician Balance
Beam Scale (Healthometer, Illinois, USA). Height was
measured by the Holtain Harpenden standiometer
(Holtain Ltd, Crosswell, UK). Body mass index was
calculated by dividing the weight in kilogram by the
square of the height in meters. Grip strength was mea-
sured using a dynamometer JAMAR hand dynamome-
ter 5030JI, Sammons Preston, Bolingbrook, IL. If there
was pain, arthritis, or previous surgery on that hand, grip
strength was not tested in that hand. Research staff first
demonstrated the procedure, followed by the participant
practicing the movement with the arm bent at the elbow
resting on the table. The average for four readings of
right and left sides were used. Self-rated SES was
assessed by asking participants to place a mark on a
picture of an upright ladder with ten rungs, with the top
rung representing people who have the most money, the
most education, and the most respected jobs, and the
bottom rung representing people at the other extreme
(SES ladder). This is a subjective measure of social
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status developed by the John D and Catherine T
MacArthur Research Network on Socioeconomic Status
and Health, and has been associated with key health
outcomes in various population surveys of different
cultural and ethnic groups (Adler et al. 2000), and had
been applied in the Hong Kong population to examine
gender differences in socioeconomic status (Woo et al.
2008).
Multi-morbidity was defined as having two or more
chronic diseases. Dependency was dichotomized into
two groups: those with difficulty in performing two to
three instrumental activities of daily living (score 2–3)
versus those with no difficulty or only difficulty with
one IADL item. Frailty status was separated into two
groups: “robust” (score 0) and “frail” (score ≥1). Partic-
ipants were categorized into seven mutually exclusive
groups for analyses: multi-morbidity alone (A), depen-
dency alone (B), frailty alone (C), A+B, A+C, B+C, and
finally all three syndromes combined (A+B+C).
Outcome measures at follow-up
All participants were followed up for 4 years and
returned for assessment during the fifth year. Mortality
was documented through a search of the Hong Kong
Death Registry. The cutoff date for determining mor-
tality was 31 March 2012. Physical limitation at
follow-up was assessed using the following two ques-
tions: do you have any difficulty in climbing stairs
(possible answers: no, a little, a lot); do you have any
difficulty in carrying out the following household ac-
tivities such as moving chairs or tables (possible an-
swers: no, a little, a lot). Participants were categorized
as having physical limitation if the answer to either
question was “a little” or “a lot,” while those who
answered “no” to both questions were categorized as
having no physical limitation. Increasing physical lim-
itation was defined as progression from those without
limitation at baseline to having limitation at follow-up.
The GDS was repeated and those with GDS ≥8 but
with GDS <8 at baseline were classified as developing
depression. The number of drugs used was document-
ed. Polypharmacy was defined as taking four or more
drugs at follow-up (the crude prevalence was used).
Statistical analysis
Statistical analyses were performed using the statistical
package SAS, version 9.1.3 (SAS Institute, Inc., Cary,
NC, USA). Multi-morbidity, dependency, frailty and
SES were analyzed with different health outcomes by
chi square tests. To assess the risk prediction ability of
SES for different outcomes in addition to other risk
factors, two models (M1 and M2) were compared. M1
included sex, age, and combination of multi-morbidity,
dependency, and frailty. M2 contained covariates in
M1 and SES. Death, increase in physical limitation
after 4 years, and newly developed depressive symp-
toms were analyzed by Cox proportional hazard re-
gression. The area under the curve (AUC) estimated
by Harrell C statistic was used to measure the concor-
dance of predictive values with actual outcomes. Drug
use (≥4) at 4 years was analyzed by logistic regression.
The AUC was estimated by C statistic. AUCs were
compared using Wilcoxon tests between them.
Reclassification improvement was calculated using
the net reclassification improvement (NRI) index and
the integrated discrimination improvement (IDI) index
(Lluis-Ganella et al. 2012; Cook and Ridker 2009) The
NRI distinguishes movements in correct direction (up
for cases and down for non-cases). Ideally, the predict-
ed probabilities would move higher (up a category) for
cases and lower (down a category) for non-cases. The
NRI is defined as:
NRI ¼ Pr up casejð Þ−Pr down casejð Þ½ 
þ Pr down non−casejð Þ−Pr up non−casejð Þ½  ¼ RIcases þ RInon−cases
where Pr stands for probability and RI stands for rela-
tive improvement.
The IDI is the difference in Yates slopes between
two models, which is the mean difference in predicted
probabilities between cases and non-cases. The IDI is
defined as:
IDI ¼ avePcases−avePnon−casesð Þnew model
− avePcases−avePnon−casesð Þold model
where P is the predicted probability. The terms in
parentheses are the Yates slopes for the two models.
For the assessment of reclassification improvement,
we defined four risk categories (low, intermediate–low,
intermediate–high, and high) by using 0–4.9, 5–9.9,
10–19.9, and 20 % or above. All statistical tests were
two-sided. A p value of <0.05 was considered statisti-
cally significant.
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Results
Of 4,000 participants, 248 had died by the fifth year of
follow-up, while 599 declined to return (Fig. 1). Those
who did not return were older, were more dependent,
and had higher frailty status. Up till March 2102, a
further 463 people had died at the end of a mean
follow-up period of 9 years. The frequency of each of
the three states at baseline is shown in Fig. 2, showing
that these syndromes may occur independent of each
other, and also have varying extent of overlap. Fifteen
percent of the cohort did not have any of these syn-
dromes. Of the remaining participants, nearly one third
had multi-morbidity and frailty (pre-frail and frail),
while all three syndromes were present in 11 %. The
prevalence for each of the five frailty domains was
having no energy (6.2 %), grip strength falling into
the first quartile (23.7 %), walking speed measurement
in the slowest quartile (24.6 %), PASE score in the
lowest quartile (25 %), and body mass index
<18.5 kg/m2 (5.4 %). All syndromes as well as socio-
economic status were significantly related with all
health outcomes examined, using Chi square test not
adjusted for multiplicity (Table 1). The relationship
between syndromes and health outcomes (mortality
after a mean of 9 years, increase in physical limitation,
depression, and number of drugs at follow-up after
4 years) is shown in Table 2. For mortality, risk is
increased only for combinations of syndromes that
included frailty, as well as older age and being male,
the AUC being 0.723. Being in the lowest third of the
SES ladder also increased mortality, but addition of
SES, only marginally increased the prediction accura-
cy by 0.3 %, although the increase is statistically sig-
nificant (IDI=0.003, p<0.05). This suggests that while
SES independently predicts mortality, the magnitude
of the impact is small in the presence of other factors in
the model.
Both multi-morbidity and frailty status alone were
associated with increase in physical limitation at
4 years, while significant associations were observed
for all combinations of the three syndromes, the stron-
gest associations being seen for combinations includ-
ing frailty status. Being male reduced the risk of in-
creasing physical limitation by half, while age in-
creased the risk, the AUC being 0.661. Again, low
SES ranking was an independent risk factor to increas-
ing physical limitation, although the contribution to the
prediction model, though statistically significant, was
small (IDI=0.002). No participant with dependency
alone developed depressive symptoms at follow-up.
Only a combination of all three syndromes, and age
per se, was associated with the occurrence of depres-
sive symptoms at 4 years, while being male conferred
reduced risk (M1). Low SES increased the risk of
depressive symptoms by over threefold as did the
coexistence of all three syndromes in model 2, the
AUC being 0.677. Inclusion of SES increased the
predictive power by 0.9 % using IDI and 13.5 % using
NRI. Multi-morbidity, but not frailty status or depen-
dency, and all syndrome combinations that included
multi-morbidity were associated with high ORs for use
of≥four medications, the values ranging from 5 to 11.
Being male, but not increasing age, was associated
with increased drug use, the AUC for this prediction
model being 0.691. SES, though not independently
associated with drug use, contributed slightly to pre-
diction accuracy (2.9 % using NRI)
Discussion
The findings of this study show that multi-morbidity,
dependency, and frailty are different constructs that
may occur singly or in various combinations in older
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different health outcomes. Furthermore, while socio-
economic status is known to influence health outcomes
(Siegrist and Marmot 2006), socioeconomic status on-
ly marginally improves outcome prediction when these
syndromes are taken into account. For depression as a
health outcome, other than the known influence of
gender, it is interesting that coexistence of all three
syndromes rather that age is the significant contributor,
in addition to socioeconomic status. This observation
enlarges on the dimensions of previous studies exam-
ining only multi-morbidity and patterns of chronic
diseases and quality of life (Kim et al. 2012) and the
bi-directional relationship between mental and physi-
cal multi-morbidity in the context of deprivation
(Mercer et al. 2012). As expected, multi-morbidity is
the overriding factor for polypharmacy. The high odds
ratio for the combination of multi-morbidity and de-
pendency may be expected in view of the close rela-
tionship between disease and disability. The findings
are compatible with a study of 1,002 women with
impairments in domains of physical functioning aged
65 years and over in the USA, which found that other
than presence of specific diseases, multi-morbidity,
frailty, and difficulty with instrumental activities of
daily living were associated with increase use of pre-
scription drugs (Crentsil et al. 2010). Such profiling
would identify patients as potential targets for
polypharmacy interventions.
The underlying biological mechanism accounting
for the protective effect of the male gender on physical
limitation and depressive symptoms is uncertain,
Possible mechanisms may include higher prevalence
of musculoskeletal diseases such as arthritis and oste-
oporosis among women (Woo et al. 2004, 2009a)
giving rise to greater physical limitation and depres-
sion as a result of pain or disability. Lower muscle
mass and power in women compared with men may
also explain the greater increase in physical limitation
in women (Woo et al. 2009b). A higher prevalence of
depression among elderly women in Hong Kong has
also been documented (Woo et al. 1994).
The findings of this study lend support to the con-
cept that frailty represents a phenomenon of physio-
logical dysregulation with ageing, distinct from disease
and disability (Fried et al. 2009). Dysregulation in
individual physiological systems such as anemia, in-
flammation, insulin-like growth factor, and others have
been studied, and the cumulative number of systems
abnormality undermines homeostatic adaptive capaci-
ty resulting in frailty and associated adverse outcomes.
Although there is overlap, there are subpopulations
with just one of these syndromes. On the other hand,
the mathematical model of frailty proposed by
Mitnitski and Rockwood uses a cumulative deficit
approach, which includes disease and disability, with
frailty being represented mathematically as an end
product of a balance between environmental damage
and time to recovery (Mitnitski et al. 2013). Interest-
ingly, both approaches provide similar predictive pow-
er for mortality and incident physical limitation (Woo
et al. 2012). The frailty phenotype classification pro-





















Fig. 2 Frequency (in per-
cent) of three syndromes,
n=4,000. Six hundred
(15.0 %) subjects did not
have any of the three syn-
dromes. Dagger, any diffi-
culty with meals, house-
work, or shopping; double
dagger, pre-frail/frail
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function with age, which represents a separate entity to
presence of disease or disability.
The clinical implication of the study is that in care of
older patients, these characteristics should form an im-
portant part of clinical assessment. Detection of these
syndromes through screening may allow formulation of
interventional strategies to reduce adverse outcomes.
Clinical management of older people should move from
the traditional medical model of being disease-centered
to being centered on function and frailty. This shift
should be taken into account in the formulation of
guidelines, service planning, as well as the conduct of
randomized controlled trials of interventions or treat-
ment. Depending on the health outcome of interest,
difference syndromes may be used in trials either in
creating samples stratified according to syndrome clas-
sification or as a covariate in analyzing effectiveness of
interventions. The inclusion of these syndromes in re-
search settings would be important in improving
evidence-based treatments, interventions, and service
delivery models in the primary and secondary care
settings (Valderas et al. 2009; Huntley et al. 2012;
Guthrie et al. 2012). Failure to include frailty status
may also explained the discrepancies in results of inter-
vention trials in the community setting for improving
outcomes in patients with multi-morbidity, defined as
the presence of two or more chronic conditions (Smith
et al. 2012).
There are limitations in this study. The sample is not
representative of the general Hong Kong population, in
that the education level is higher. Therefore, the baseline
prevalence data may not be representative. The follow-
up data may be subject to bias towards younger age and
those with better frailty status, since these participants
were more likely to return. We did not use detailed
assessments of physical limitations, and the existence
of disease was self-reported and not by doctor's exami-
nation. Other health outcome measures such as hospi-
talization were not included. It is uncertain whether the
findings may be extrapolated to the whole population or
non-Chinese populations. The strengths of the study
include the large sample of community living older
people, the inclusion of a large number of variables
enabling the three syndromes to be examined simulta-
neously together with socioeconomic status, and the
prospective design. In spite of the limitations, we can
conclude that inclusion of frailty status as well as multi-
morbidity and dependency are key contributors in dif-
ferent ways to different health outcomes, and ideally
should be included in health outcomes research in older
people, in intervention trials, management guidelines,
and service planning.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
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